As of 3:59pm ET
| -1.15 / -0.91%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 147.00, with a high estimate of 165.00 and a low estimate of 40.00. The median estimate represents a +17.68% increase from the last price of 124.91.
The current consensus among 7 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.